The neurorehabilitation devices market size has grown rapidly in recent years. It will grow from $2.07 billion in 2025 to $2.32 billion in 2026 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to rising stroke incidence, growth in rehabilitation centers, increasing awareness of neurorehabilitation, advancements in assistive devices, expansion of physical therapy services.
The neurorehabilitation devices market size is expected to see rapid growth in the next few years. It will grow to $3.58 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to aging population growth, demand for home care rehabilitation, technological innovation in exoskeletons, rising neurological injury cases, increased healthcare funding. Major trends in the forecast period include growing adoption of robotic rehabilitation systems, rising use of wearable neurorehabilitation devices, expansion of home-based rehabilitation programs, increased focus on personalized therapy plans, integration of cognitive and physical rehabilitation.
The increasing prevalence of neurological diseases is increasingly supporting the expansion of the neurorehabilitation devices market going forward. The growing number of neurological disease cases is influenced by factors such as aging populations, improved diagnostic capabilities, greater awareness, and rising stress and mental health concerns. Neurorehabilitation devices are used to support patients with neurological diseases by assisting in the recovery of motor, cognitive, and sensory functions through targeted therapies and stimulation techniques. For example, in May 2025, according to Headway, a UK-based non-profit organization, 335,409 people in the UK were admitted to hospitals during 2023-2024 due to acquired brain injury. As a result, the increasing prevalence of neurological diseases is strengthening demand for neurorehabilitation devices.
Leading companies operating in the neurorehabilitation devices market are focusing on developing innovative products, such as hyper-sensitive controllers, to enhance precision and patient engagement during rehabilitation therapy. A hyper-sensitive controller is designed to respond accurately to subtle user movements or neural signals. For example, in February 2023, MindMaze, a Switzerland-based digital neurotherapeutics company, launched Izar, a portable smart peripheral device that improves hand motor function in patients with neurological conditions including stroke and Parkinson’s disease. The device detects fine grasp forces and wrist movements to enable precise training and assessment, supporting both in-clinic and remote rehabilitation.
In August 2023, ReWalk Robotics Ltd., an Israel-based medical device company, acquired AlterG for $19 million. This acquisition is intended to broaden ReWalk’s product portfolio and strengthen its position in the rehabilitation and mobility market by combining AlterG’s anti-gravity treadmill technology with its existing exoskeleton solutions. AlterG is a US-based provider of anti-gravity systems used in physical and neurological rehabilitation.
Major companies operating in the neurorehabilitation devices market are ReWalk Robotics Ltd., Ottobock SE & Co. KGaA, Helius Medical Technologies Inc., Bioness Inc., Neofect Co. Ltd., Tyromotion GmbH, Ekso Bionics Holdings Inc., Reha Technology AG, Kinestica Inc., Motus Nova, NeuroGym, NeuroMetrix Inc., Rehab‑Robotics Company Limited, Rex Bionics Ltd., Saebo Inc., Bionik Laboratories Corp., Medtronic plc, Abbott Laboratories, Hocoma AG, Cyberdyne Inc., MindMaze SA, NeuroPace Inc., Paradromics Inc., Cognixion.
North America was the largest region in the neurorehabilitation devices market in 2025. The regions covered in the neurorehabilitation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurorehabilitation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the neurorehabilitation devices market by increasing costs of robotic components, sensors, and electronic modules, particularly impacting neurorobotics and wearable devices in North America and Europe. Rehabilitation centers face higher equipment costs. On the positive side, tariffs have supported domestic manufacturing and accelerated regional innovation ecosystems.
The neurorehabilitation devices market research report is one of a series of new reports that provides neurorehabilitation devices market statistics, including neurorehabilitation devices industry global market size, regional shares, competitors with a neurorehabilitation devices market share, detailed neurorehabilitation devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurorehabilitation devices industry. This neurorehabilitation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurorehabilitation devices are specialized tools that assist recovery in patients with neurological injuries or diseases, aiming to restore lost movement, function, and independence after conditions such as stroke or spinal cord injury.
The primary products in the neurorehabilitation devices market include brain-computer interfaces, wearable devices, non-invasive stimulators, and others. A brain-computer interface (BCI) is a technology that enables direct interaction between the brain and external devices, bypassing traditional neuromuscular pathways. These devices are used in applications such as stroke rehabilitation, Parkinson’s disease management, brain and spinal cord injury treatment, cerebral palsy, multiple sclerosis, and others. The end users include rehabilitation centers, hospitals and clinics, home care environments, and others.
The neurorehabilitation devices market consists of sales of robotic exoskeletons, neuroprosthetics, brain-computer interfaces (BCI), functional electrical stimulation (FES) devices, transcranial magnetic stimulation (TMS) devices, virtual reality (VR), and rehabilitation systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The neurorehabilitation devices market size is expected to see rapid growth in the next few years. It will grow to $3.58 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to aging population growth, demand for home care rehabilitation, technological innovation in exoskeletons, rising neurological injury cases, increased healthcare funding. Major trends in the forecast period include growing adoption of robotic rehabilitation systems, rising use of wearable neurorehabilitation devices, expansion of home-based rehabilitation programs, increased focus on personalized therapy plans, integration of cognitive and physical rehabilitation.
The increasing prevalence of neurological diseases is increasingly supporting the expansion of the neurorehabilitation devices market going forward. The growing number of neurological disease cases is influenced by factors such as aging populations, improved diagnostic capabilities, greater awareness, and rising stress and mental health concerns. Neurorehabilitation devices are used to support patients with neurological diseases by assisting in the recovery of motor, cognitive, and sensory functions through targeted therapies and stimulation techniques. For example, in May 2025, according to Headway, a UK-based non-profit organization, 335,409 people in the UK were admitted to hospitals during 2023-2024 due to acquired brain injury. As a result, the increasing prevalence of neurological diseases is strengthening demand for neurorehabilitation devices.
Leading companies operating in the neurorehabilitation devices market are focusing on developing innovative products, such as hyper-sensitive controllers, to enhance precision and patient engagement during rehabilitation therapy. A hyper-sensitive controller is designed to respond accurately to subtle user movements or neural signals. For example, in February 2023, MindMaze, a Switzerland-based digital neurotherapeutics company, launched Izar, a portable smart peripheral device that improves hand motor function in patients with neurological conditions including stroke and Parkinson’s disease. The device detects fine grasp forces and wrist movements to enable precise training and assessment, supporting both in-clinic and remote rehabilitation.
In August 2023, ReWalk Robotics Ltd., an Israel-based medical device company, acquired AlterG for $19 million. This acquisition is intended to broaden ReWalk’s product portfolio and strengthen its position in the rehabilitation and mobility market by combining AlterG’s anti-gravity treadmill technology with its existing exoskeleton solutions. AlterG is a US-based provider of anti-gravity systems used in physical and neurological rehabilitation.
Major companies operating in the neurorehabilitation devices market are ReWalk Robotics Ltd., Ottobock SE & Co. KGaA, Helius Medical Technologies Inc., Bioness Inc., Neofect Co. Ltd., Tyromotion GmbH, Ekso Bionics Holdings Inc., Reha Technology AG, Kinestica Inc., Motus Nova, NeuroGym, NeuroMetrix Inc., Rehab‑Robotics Company Limited, Rex Bionics Ltd., Saebo Inc., Bionik Laboratories Corp., Medtronic plc, Abbott Laboratories, Hocoma AG, Cyberdyne Inc., MindMaze SA, NeuroPace Inc., Paradromics Inc., Cognixion.
North America was the largest region in the neurorehabilitation devices market in 2025. The regions covered in the neurorehabilitation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurorehabilitation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the neurorehabilitation devices market by increasing costs of robotic components, sensors, and electronic modules, particularly impacting neurorobotics and wearable devices in North America and Europe. Rehabilitation centers face higher equipment costs. On the positive side, tariffs have supported domestic manufacturing and accelerated regional innovation ecosystems.
The neurorehabilitation devices market research report is one of a series of new reports that provides neurorehabilitation devices market statistics, including neurorehabilitation devices industry global market size, regional shares, competitors with a neurorehabilitation devices market share, detailed neurorehabilitation devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurorehabilitation devices industry. This neurorehabilitation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurorehabilitation devices are specialized tools that assist recovery in patients with neurological injuries or diseases, aiming to restore lost movement, function, and independence after conditions such as stroke or spinal cord injury.
The primary products in the neurorehabilitation devices market include brain-computer interfaces, wearable devices, non-invasive stimulators, and others. A brain-computer interface (BCI) is a technology that enables direct interaction between the brain and external devices, bypassing traditional neuromuscular pathways. These devices are used in applications such as stroke rehabilitation, Parkinson’s disease management, brain and spinal cord injury treatment, cerebral palsy, multiple sclerosis, and others. The end users include rehabilitation centers, hospitals and clinics, home care environments, and others.
The neurorehabilitation devices market consists of sales of robotic exoskeletons, neuroprosthetics, brain-computer interfaces (BCI), functional electrical stimulation (FES) devices, transcranial magnetic stimulation (TMS) devices, virtual reality (VR), and rehabilitation systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Neurorehabilitation Devices Market Characteristics
3. Neurorehabilitation Devices Market Supply Chain Analysis
4. Global Neurorehabilitation Devices Market Trends and Strategies
5. Neurorehabilitation Devices Market Analysis of End Use Industries
7. Global Neurorehabilitation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Neurorehabilitation Devices Total Addressable Market (TAM) Analysis for the Market
9. Neurorehabilitation Devices Market Segmentation
10. Neurorehabilitation Devices Market Regional and Country Analysis
11. Asia-Pacific Neurorehabilitation Devices Market
12. China Neurorehabilitation Devices Market
13. India Neurorehabilitation Devices Market
14. Japan Neurorehabilitation Devices Market
15. Australia Neurorehabilitation Devices Market
16. Indonesia Neurorehabilitation Devices Market
17. South Korea Neurorehabilitation Devices Market
18. Taiwan Neurorehabilitation Devices Market
19. South East Asia Neurorehabilitation Devices Market
20. Western Europe Neurorehabilitation Devices Market
21. UK Neurorehabilitation Devices Market
22. Germany Neurorehabilitation Devices Market
23. France Neurorehabilitation Devices Market
24. Italy Neurorehabilitation Devices Market
25. Spain Neurorehabilitation Devices Market
26. Eastern Europe Neurorehabilitation Devices Market
27. Russia Neurorehabilitation Devices Market
28. North America Neurorehabilitation Devices Market
29. USA Neurorehabilitation Devices Market
30. Canada Neurorehabilitation Devices Market
31. South America Neurorehabilitation Devices Market
32. Brazil Neurorehabilitation Devices Market
33. Middle East Neurorehabilitation Devices Market
34. Africa Neurorehabilitation Devices Market
36. Neurorehabilitation Devices Market Competitive Landscape and Company Profiles
37. Neurorehabilitation Devices Market Other Major and Innovative Companies
40. Neurorehabilitation Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Neurorehabilitation Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses neurorehabilitation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for neurorehabilitation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurorehabilitation devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Neurorobotics; Brain-Computer Interface; Wearable Devices; Non-Invasive Stimulators; Other Products2) By Application: Stroke; Parkinson's Disease; Brain And Spinal Cord Injury; Cerebral Palsy; Multiple Sclerosis; Other Applications
3) By End User: Rehabilitation Centers; Hospitals And Clinics; Home Care; Other End Users
Subsegments:
1) By Neurorobotics: Robotic Exoskeletons; Robotic Rehabilitation Devices; Assistive Robots For Gait Training2) By Brain-Computer Interface: Invasive Brain-Computer Interfaces; Non-Invasive Brain-Computer Interfaces; Hybrid Brain-Computer Interfaces
3) By Wearable Devices: Smart Gloves; Smart Sensors; Exosuits and Wearable Robotics
4) By Non-Invasive Stimulators: Transcranial Magnetic Stimulation (TMS) Devices; Transcranial Direct Current Stimulation (tDCS) Devices; Functional Electrical Stimulation (FES) Devices
5) By Other Products: Virtual Reality Rehabilitation Systems; Software Platforms For Neurorehabilitation; Cognitive Training Devices
Companies Mentioned: ReWalk Robotics Ltd.; Ottobock SE & Co. KGaA; Helius Medical Technologies Inc.; Bioness Inc.; Neofect Co. Ltd.; Tyromotion GmbH; Ekso Bionics Holdings Inc.; Reha Technology AG; Kinestica Inc.; Motus Nova; NeuroGym; NeuroMetrix Inc.; Rehab‑Robotics Company Limited; Rex Bionics Ltd.; Saebo Inc.; Bionik Laboratories Corp.; Medtronic plc; Abbott Laboratories; Hocoma AG; Cyberdyne Inc.; MindMaze SA; NeuroPace Inc.; Paradromics Inc.; Cognixion
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Neurorehabilitation Devices market report include:- ReWalk Robotics Ltd.
- Ottobock SE & Co. KGaA
- Helius Medical Technologies Inc.
- Bioness Inc.
- Neofect Co. Ltd.
- Tyromotion GmbH
- Ekso Bionics Holdings Inc.
- Reha Technology AG
- Kinestica Inc.
- Motus Nova
- NeuroGym
- NeuroMetrix Inc.
- Rehab‑Robotics Company Limited
- Rex Bionics Ltd.
- Saebo Inc.
- Bionik Laboratories Corp.
- Medtronic plc
- Abbott Laboratories
- Hocoma AG
- Cyberdyne Inc.
- MindMaze SA
- NeuroPace Inc.
- Paradromics Inc.
- Cognixion
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.32 Billion |
| Forecasted Market Value ( USD | $ 3.58 Billion |
| Compound Annual Growth Rate | 11.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
